US move affects Africa's vax driveThe US Food and Drug Administration's recent decision to limit the use of the Johnson & Johnson Covid-19 vaccine to adults who cannot or will not get another vaccine will have profound consequences for African countries. Only 8% have received the J&J vaccine. So, the FDA's decision will have little material impact in America. This will have major implications for African countries' ongoing efforts to stimulate vaccine demand and safeguard their populations. Had the Africa CDC known in advance of the FDA's decision, it could have addressed anticipated concerns across the continent.

Source: The North Africa Journal June 07, 2022 12:24 UTC